Physician profile
David Bernstein
NPI 1982960704
$14,446.91
in general payments reported to CMS, 2019-2025
14 companies · $4,354 in 2025
The $4,354 reported for 2025 was more than what 89% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,279 · 2020: $381 · 2021: $3,799 · 2022: $708 · 2023: $463 · 2024: $1,462 · 2025: $4,354.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,469 · Food and Beverage: $2,810.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,468.87 |
| Food and Beverage | $2,810.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $7,177.17 | 2019-2024 | Da Vinci Surgical System |
| Medtronic, INC. | $6,028.76 | 2021-2025 | Signia, Ligasure, Sonicision |
| Ethicon US, LLC | $406.68 | 2019-2025 | Stratafix, Vistaseal, Harmonic |
| Covidien LP | $365.00 | 2020 | |
| Novo Nordisk INC | $159.60 | 2024-2025 | Wegovy |
| Biotissue Holdings INC. | $136.23 | 2024 | |
| Baxter Healthcare | $42.63 | 2021-2022 | |
| Dexcom, INC. | $40.95 | 2022 | |
| Apollo Endosurgery US INC | $17.80 | 2021 | |
| Acell, INC. | $16.32 | 2020 | |
| Kci USA, INC. | $14.73 | 2021 | |
| Solventum Corporation | $14.63 | 2024 | Activ.A.C. |
| Pentax of America, INC. | $13.68 | 2023 | Imagina |
| Reshape Lifesciences INC. | $12.73 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Bernstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.